- Home
- SAN vs ABT Comparison
SAN vs ABT Comparison
Compare SAN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SAN | ABT |
|---|---|---|
| Founded | 1857 | 1888 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.8B | 189.6B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | SAN | ABT |
|---|---|---|
| Price | $13.11 | $115.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 18 |
| Target Price | N/A | ★ $141.00 |
| AVG Volume (30 Days) | ★ 15.8M | 9.4M |
| Earning Date | 01-01-0001 | 04-23-2026 |
| Dividend Yield | 1.40% | ★ 2.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.72 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $24.67 | $8.92 |
| Revenue Next Year | $5.22 | $7.39 |
| P/E Ratio | ★ $11.21 | $30.85 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $5.54 | $105.27 |
| 52 Week High | $13.24 | $141.23 |
Technical Indicators
Market Signals| Indicator | SAN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 58.59 | 55.40 |
| Support Level | $11.82 | $105.27 |
| Resistance Level | $13.11 | $129.65 |
| Average True Range (ATR) | 0.29 | 1.86 |
| MACD | 0.04 | 0.98 |
| Stochastic Oscillator | 89.67 | 96.94 |
Price Performance
Historical ComparisonAbout SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.